Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder
Gihyun Yoon, Ismene L. Petrakis, John H. Krystal
JAMA Psychiatry March 1, 2019 DOI: 10.1001/jamapsychiatry.2018.3990 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Case report Peer reviewed |
|---|---|
| Interventions | Naltrexone Ketamine |
| Topics | Addiction Depression Esketamine Ketamine |
| Citations | 152 |
| Key findings | Naltrexone pretreatment does not diminish the antidepressant effects of ketamine. |
Abstract
This study examines whether naltrexone pretreatment interferes with the antidepressant effects of ketamine.
Comparable studies
Other randomized controlled trials on ketamine for addiction, most cited first.
Citations in the library
Cited by 82
- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation American Journal of Psychiatry March 17, 2021
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective Psychiatry and Clinical Neurosciences June 19, 2019
- Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability Molecular Psychiatry April 15, 2021
- Ketamine: A tale of two enantiomers Journal of Psychopharmacology November 6, 2020
- Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials Psychopharmacology April 1, 2022
and 77 more in the library